Skin and soft-tissue infections: Factors associated with mortality and re-admissions

被引:18
|
作者
Macia-Rodriguez, Cristina [1 ]
Alende-Castro, Vanesa [1 ]
Vazquez-Ledo, Lourdes [1 ]
Novo-Veleiro, Ignacio [1 ]
Gonzalez-Quintela, Arturo [1 ]
机构
[1] Hosp Univ Santiago de Compostela, Serv Med Interna, La Coruna, Spain
来源
关键词
Skin and soft-tissue infections; Healthcare-associated infections; ESBL-producing bacteria; Mortality; Readmission; COMPLICATED SKIN;
D O I
10.1016/j.eimc.2016.02.030
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Skin and soft-tissue infections (SSTIs) are common and are linked to a wide variety of clinical conditions. Few studies have analysed the factors associated with mortality and re-admissions in medical patients with SSTIs. Accordingly, this study sought to describe the clinical and microbiological characteristics of patients diagnosed with SSTIs, and identify mortality and re-admission related factors. Patients and methods: A total of 308 patients were included in the study. Clinical, socio-demographic and microbiological characteristics were collected. Univariate and logistic regression multivariate analyses were performed in order to identify factors associated with mortality and re-admission. Results: The bacteria responsible were identified in 95 (30.8%) patients, with gram-positive bacteria being, isolated in 67.4% and gram-negative in 55.8% of cases. Multi-resistant bacteria were frequent (39%), and the initial empirical treatment proved inadequate in 25.3% of all cases. In-hospital mortality was 14.9%; the related variables were heart failure (OR= 5.96; 95%CI: 1.93-18.47), chronic renal disease (OR= 6.04; 95%CI: 1.80-20.22), necrotic infection (OR =4.33; 95%CI: 1.26-14.95), and inadequate empirical treatment (OR =44.74; 95%CI: 5.40-370.73). Six-month mortality was 8%, with the main related factors being chronic renal disease (OR: 3.03; 95%CI: 1.06-8.66), and a Barthel Index score of under 20 (OR: 3.62; 95%CI: 1.17-11.21). Re-admission was necessary in 26.3% of cases, with the readmission-related variables being male gender (OR: 2.12; 95%CI: 1.14-3.94), peripheral vascular disease (OR: 3.05; 95%CI: 1.25-7.41), and an age-adjusted Charison Comorbidity Index score of over 3 (OR: 3.27; 95%CI: 1.40-7.63). Conclusions: Clinical variables such as heart failure, chronic renal disease, peripheral vascular disease, and necrotic infection could help identify high-risk patients. The main factor associated with higher mortality was inadequate initial empirical treatment. Physicians should consider gram-negative, and even extended-spectrum beta-lactamase-producing bacteria when assigning initial empirical treatment for SSTIs, especially in healthcare-associated cases. (C) 2016 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 50 条
  • [41] TREATMENT OF SKIN AND SOFT-TISSUE INFECTIONS WITH CEFSULODIN
    MOGABGAB, WJ
    REVIEWS OF INFECTIOUS DISEASES, 1984, 6 : S721 - S727
  • [42] SKIN AND SOFT-TISSUE FUNGAL-INFECTIONS
    BRADSHER, RW
    CURRENT OPINION IN INFECTIOUS DISEASES, 1990, 3 (05) : 687 - 690
  • [43] TREATMENT OF BACTERIAL SKIN AND SOFT-TISSUE INFECTIONS
    FILE, TM
    TAN, JS
    SURGERY GYNECOLOGY & OBSTETRICS, 1991, 172 : 17 - 24
  • [44] Factors associated with mortality in patients with extremity necrotizing soft-tissue infections: a single academic center experience
    Keita Nagira
    Tomofumi Ogoshi
    Keiichi Akahori
    Shinpei Enokida
    Makoto Enokida
    Takahiro Ueda
    Masato Homma
    Hideki Nagashima
    Langenbeck's Archives of Surgery, 408
  • [45] Factors associated with mortality in patients with extremity necrotizing soft-tissue infections: a single academic center experience
    Nagira, Keita
    Ogoshi, Tomofumi
    Akahori, Keiichi
    Enokida, Shinpei
    Enokida, Makoto
    Ueda, Takahiro
    Homma, Masato
    Nagashima, Hideki
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [46] OFFICE LABORATORY DIAGNOSIS OF SKIN AND SOFT-TISSUE INFECTIONS
    TODD, JK
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (01) : 84 - 87
  • [47] Is there still a role for vancomycin in skin and soft-tissue infections?
    Savoldi, Alessia
    Azzini, Anna M.
    Baur, David
    Tacconelli, Evelina
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (02) : 120 - 130
  • [48] TREATMENT OF SKIN AND SOFT-TISSUE INFECTIONS WITH ORAL CIPROFLOXACIN
    FASS, RJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 153 - 157
  • [49] CIPROFLOXACIN VERSUS CEFTAZIDIME IN SKIN AND SOFT-TISSUE INFECTIONS
    THADEPALLI, H
    MATHAI, D
    CHUAH, SK
    BANSAL, MB
    JOURNAL OF CHEMOTHERAPY, 1989, 1 (01) : 31 - 34
  • [50] THE ROLE OF CEPHALEXIN IN THE TREATMENT OF SKIN AND SOFT-TISSUE INFECTIONS
    DERRICK, CW
    REILLY, K
    POSTGRADUATE MEDICAL JOURNAL, 1983, 59 : 43 - 46